Acclarent Raises $26 Million
Acclarent Inc., a Menlo Park, Calif.-based developer of surgical devices for treating ear, nose and throat ailments, has raised $26 million in fourth-round funding. Johnson & Johnson Development Corp. joined return backers New Enterprise Associates, Delphi Ventures, Versant Ventures and Meritech Capital Partners. Last month, Acclarent withdrew registration for an $86.25 million IPO, citing "unfavorable market conditions."
12 January 2009•2 mins read
